The Impact of Sugar Control on Pancreatic Cancer Progression for the Elderly

A Case Study and Review of Current Evidence


Abstract views: 91 / PDF downloads: 33

Authors

  • Alex Chirayath HS of Innovation – Katy, USA
  • Cathy Obawole HS of Innovation – Katy, USA
  • Omer Ulucan Austin Community College, USA
  • Yakup Bayar University of Texas at Austin, USA

DOI:

https://doi.org/10.31039/plic.2024.11.245

Keywords:

Pancreatic cancer, Nutrition, Oncology, Sugar

Abstract

Pancreatic cancer is a type of cancer that originates in the pancreas, an organ that aids in digestion and blood sugar regulation. It is characterized as an aggressive type of cancer that presents with symptoms that often go undetected. In 2024, there were an estimated 66,440 new cases of pancreatic cancer and an estimated 51,170 deaths from pancreatic cancer, with a 5-year relative survival rate of 12.8% (SEER, 2023). While traditional medical interventions such as surgery and chemotherapy continue to be the cornerstone of treatment, there is an emerging focus on the potential impact of dietary and nutritional factors in both preventing and managing pancreatic cancer. This approach is particularly relevant for elderly patients due to the heightened risk associated with surgery at their age and their reduced tolerance to chemotherapy regimens. This paper presents a compelling case study of a pancreatic cancer patient who adopted a sugar-restricted diet, resulting in a notable decrease in the tumor marker CA 19-9, which is commonly associated with pancreatic cancer. Building on this individual case study, this paper provides a comprehensive review of current scientific literature to examine the potential relationship between sugar consumption and pancreatic cancer development and progression. By examining this intersection of nutrition and oncology, this study aims to expound upon possible alternative or complementary approaches to pancreatic cancer management, especially for vulnerable populations such as the elderly. This research could lead to new strategies for improving outcomes and quality of life in pancreatic cancer care.

References

Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011). Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. European Journal of Cancer, 47(13), 1928–1937. https://doi.org/10.1016/j.ejca.2011.03.003

Cancer of the pancreas - Cancer Stat Facts. (2023). SEER. https://seer.cancer.gov/statfacts/html/pancreas.html

Duan, Q., Li, H., Gao, C., Zhao, H., Wu, S., Wu, H., Wang, C., Shen, Q., & Yin, T. (2019). High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway. Journal of Experimental & Clinical Cancer Research, 38(1). https://doi.org/10.1186/s13046-019-1209-9

Epner, D. E., Bhat, A., & Mastanduno, M. (2022). Metabolic reprogramming in cancer: The Warburg effect revisited. Clinical Cancer Research, 28(3), 435-442. https://doi.org/10.1158/1078-0432.CCR-21-2345

Farias, A. J., Wu, A. H., Porcel, J., Marchand, L. L., Wilkens, L. R., Monroe, K. R., Maskarinec, G., Pandol, S. J., & Setiawan, V. W. (2020). Diabetes-related complications and pancreatic cancer incidence in the multiethnic cohort. JNCI Cancer Spectrum, 4(5). https://doi.org/10.1093/jncics/pkaa035

Gillespie, K. M., et al. (2023). The role of dietary interventions in cancer management: A review. Journal of Nutrition and Cancer, 7(2), 123-134. https://doi.org/10.1080/01635581.2023.1987524

Kubota, S., Liu, Y., Iizuka, K., Kuwata, H., Seino, Y., & Yabe, D. (2020). A review of recent findings on meal sequence: An attractive dietary approach to prevention and management of type 2 diabetes. Nutrients, 12(9), 2502. https://doi.org/10.3390/nu12092502

Khan, T. A., & Sievenpiper, J. L. (2016). Controversies about sugars: Results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes. European Journal of Nutrition, 55(2), 25-43. https://doi.org/10.1007/s00394-016-1345-3

Liao, W., Tu, Y., Wu, M., Lin, J., Wang, H., & Chien, K. (2015). Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis. BMJ, 349(jan02 3), g7371. https://doi.org/10.1136/bmj.g7371

Liu, H., Huang, D., McArthur, D. L., Boros, L. G., Nissen, N., & Heaney, A. P. (2010). Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Research, 70(15), 6368–6376. https://doi.org/10.1158/0008-5472.can-09-4615

Misra, A., et al. (2016). Diet and cancer: A review of the role of nutrition in carcinogenesis. Cancer Prevention Research, 9(11), 821-834. https://doi.org/10.1158/1940-6207.CAPR-16-0124

Nakrani, M. N., Wineland, R. H., & Anjum, F. (2023, July 17). Physiology, glucose metabolism. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK560599/

Pishdad, G. R., et al. (2021). Anti-inflammatory diets in cancer prevention and management: A review. Cancer Research and Treatment, 53(1), 27-41. https://doi.org/10.4143/crt.2021.188

Porporato, P. E. (2016). Understanding cachexia as a cancer metabolism syndrome. Oncogenesis, 5(2), e200. https://doi.org/10.1038/oncsis.2016.3

Sato, K., Hikita, H., Myojin, Y., Fukumoto, K., Murai, K., Sakane, S., Tamura, T., Yamai, T., Nozaki, Y., Yoshioka, T., Kodama, T., Shigekawa, M., Sakamori, R., Tatsumi, T., & Takehara, T. (2020). Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels. PloS One, 15(7), e0235573. https://doi.org/10.1371/journal.pone.0235573

Setiawan, V. W., Stram, D. O., Porcel, J., Chari, S. T., Maskarinec, G., Marchand, L. L., Wilkens, L. R., Haiman, C. A., Pandol, S. J., & Monroe, K. R. (2018). Pancreatic cancer following incident diabetes in African Americans and Latinos: The multiethnic cohort. Journal of the National Cancer Institute, 111(1), 27–33. https://doi.org/10.1093/jnci/djy090

Traverso, G. (2011). The role of inflammation in cancer prevention and therapy. European Journal of Cancer Prevention, 20(5), 421-427. https://doi.org/10.1097/CEJ.0b013e3283473c9e

Vecchia, C. L., et al. (1993). Refined-sugar intake and the risk of colorectal cancer in humans. Cancer Epidemiology, Biomarkers & Prevention, 2(5), 419-423. https://cebp.aacrjournals.org/content/2/5/419

Vaupel, P., & Multhoff, G. (2021). Revisiting the Warburg effect: Historical dogma versus current understanding. Journal of Physiology, 599(6), 1745–1757. https://doi.org/10.1113/jp278810

Zhang, A. M., Xia, Y. H., Lin, J. S., Chu, K. H., Wang, W. C. K., Ruiter, T. J., Yang, J. C., Chen, N., Chhuor, J., Patil, S., Cen, H. H., Rideout, E. J., Richard, V. R., Schaeffer, D. F., Zahedi, R. P., Borchers, C. H., Johnson, J. D., & Kopp, J. L. (2023). Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metabolism, 35(12), 2119-2135.e5. https://doi.org/10.1016/j.cmet.2023.10.003

Downloads

Published

2024-09-09

How to Cite

Alex Chirayath, Obawole , C., Ulucan , O., & Bayar , Y. (2024). The Impact of Sugar Control on Pancreatic Cancer Progression for the Elderly: A Case Study and Review of Current Evidence. Proceedings of London International Conferences, (11), 89–98. https://doi.org/10.31039/plic.2024.11.245

Issue

No. 11 (2024): Proceedings of London International Conference

Section

Articles

License

Copyright (c) 2024 Alex Chirayath, Cathy Obawole , Omer Ulucan , Yakup Bayar

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

Share: copy and redistribute the material in any medium or format. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution-NonCommercial-NoDerivatives-No additional restrictions.

Authors retain copyright and agree to license their articles with a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) 4.0 License.